Valuation Apollo Hospitals Enterprise Limited
Equities
APOLLOHOSP
INE437A01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,724.50 INR | -0.65% |
|
-1.24% | +9.68% |
| 02-26 | Mirxes Plans India Cancer Screening Tie-Up With Apollo Health and Lifestyle | MT |
| 02-11 | Indian Indices End Mixed on Wednesday as Investor Optimism on US-India Trade Deal Fades | MT |
Company Valuation: Apollo Hospitals Enterprise Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 417,357 | 649,346 | 619,841 | 914,010 | 951,308 | 1,110,665 | - | - |
| Change | - | 55.59% | -4.54% | 47.46% | 4.08% | 16.75% | - | - |
| Enterprise Value (EV) 1 | 442,681 | 660,331 | 636,264 | 929,451 | 976,135 | 1,160,740 | 1,153,772 | 1,147,920 |
| Change | - | 49.17% | -3.64% | 46.08% | 5.02% | 18.91% | -0.6% | -0.51% |
| P/E ratio | 270x | 61.5x | 75.7x | 102x | 65.8x | 58.2x | 46.1x | 36.4x |
| PBR | 9.07x | 11.5x | 10x | 13.2x | 11.6x | 11.3x | 9.4x | 7.66x |
| PEG | - | 0x | -3.4x | 10.51x | 1.1x | 1.8x | 1.8x | 1.4x |
| Capitalization / Revenue | 3.95x | 4.43x | 3.73x | 4.8x | 4.36x | 4.42x | 3.67x | 3.19x |
| EV / Revenue | 4.19x | 4.5x | 3.83x | 4.88x | 4.48x | 4.62x | 3.81x | 3.3x |
| EV / EBITDA | 38.9x | 30.2x | 31.7x | 38.6x | 32x | 31.2x | 25.5x | 21.1x |
| EV / EBIT | 78.5x | 41.7x | 45.7x | 53.9x | 42.5x | 40.6x | 32.2x | 26.1x |
| EV / FCF | 45.3x | 68.9x | 256x | 119x | 230x | 76.6x | 52.9x | 41.4x |
| FCF Yield | 2.21% | 1.45% | 0.39% | 0.84% | 0.43% | 1.31% | 1.89% | 2.42% |
| Dividend per Share 2 | 3 | 11.75 | 15 | 16 | 19 | 23.34 | 27.26 | 33.79 |
| Rate of return | 0.1% | 0.26% | 0.35% | 0.25% | 0.29% | 0.3% | 0.35% | 0.44% |
| EPS 2 | 10.74 | 73.42 | 56.97 | 62.5 | 100.6 | 132.6 | 167.5 | 212 |
| Distribution rate | 27.9% | 16% | 26.3% | 25.6% | 18.9% | 17.6% | 16.3% | 15.9% |
| Net sales 1 | 105,600 | 146,626 | 166,124 | 190,592 | 217,940 | 251,391 | 302,628 | 347,916 |
| EBITDA 1 | 11,374 | 21,851 | 20,065 | 24,106 | 30,548 | 37,214 | 45,243 | 54,327 |
| EBIT 1 | 5,643 | 15,844 | 13,912 | 17,236 | 22,973 | 28,603 | 35,819 | 44,047 |
| Net income 1 | 1,504 | 10,556 | 8,191 | 8,986 | 14,459 | 19,100 | 24,135 | 30,500 |
| Net Debt 1 | 25,324 | 10,985 | 16,423 | 15,441 | 24,827 | 50,075 | 43,107 | 37,256 |
| Reference price 2 | 2,902.65 | 4,516.10 | 4,310.90 | 6,356.80 | 6,616.20 | 7,724.50 | 7,724.50 | 7,724.50 |
| Nbr of stocks (in thousands) | 143,785 | 143,785 | 143,785 | 143,785 | 143,785 | 143,785 | - | - |
| Announcement Date | 6/23/21 A | 5/25/22 A | 5/30/23 A | 5/30/24 A | 5/30/25 A | - | - | - |
1INR in Million2INR
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 58.23x | 4.62x | 31.19x | 0.3% | 12.09B | ||
| 39.37x | 3.56x | 15.84x | 1.14% | 19.93B | ||
| 26.32x | 4x | 14.12x | 1.6% | 13.91B | ||
| 29.2x | 2.3x | 19.32x | 0.13% | 11.95B | ||
| 18.17x | 2.03x | 9.56x | 0.72% | 10.63B | ||
| 17.89x | 2.64x | 10.84x | 4.28% | 9.59B | ||
| 62.56x | 7.53x | 32.64x | 0.14% | 7.33B | ||
| 34.17x | 0.93x | 7.73x | 1.93% | 7.18B | ||
| 11.05x | 1.03x | 6.43x | 2.26% | 7.17B | ||
| 41.04x | 4.92x | 23.61x | 0.28% | 3.88B | ||
| Average | 33.80x | 3.36x | 17.13x | 1.28% | 10.37B | |
| Weighted average by Cap. | 33.87x | 3.33x | 16.96x | 1.26% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- APOLLOHOSP Stock
- Valuation Apollo Hospitals Enterprise Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















